DOCSLIB.ORG

Meeting Incoming Jiangsu Pharmaceutical R&D Delegation REGISTRATION

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Meeting Incoming Jiangsu Pharmaceutical R&D Delegation REGISTRATION Registration to the seminar is Free. Organization Information Sub-sector(s): Organization Name: Address (with post code): Website: canada.ccpit.org No. years in Business: ________ No. of Employees: ________ Total Sales: ________ Is your company already doing business in China? ________ Yes ________ No If Yes, for how long? ________ year(s) in which province(s)? ________________________ Is your company already exporting to China? ________Yes ________No If Yes, for how long? ________ year(s) to which province(s)? ________________________ Participant(s) Information Name: Working Title: Email: Tel: Fax: Organization Profile (one paragraph summary) (Please note this profile would be forwarded to Jiangsu delegation before the seminar) Wish list Is there any company you would like to meet particularly? ________________________ (Please Indicate the company name(s) or number(s)) Is there any company you request more information? _______________________ (Please Indicate the company name(s) or number(s) Do you request to do a self-introduction on the seminar (1-2 minutes)? ________Yes ________No Deadline for registration: April 11th, 2008 (Friday) Please Email/Fax this page to [email protected] or 416-325-2766 (Att’n Wenbo Pan) For more information, please contact 416-326-1346 (Wenbo Pan, Area Director – China, Ministry of Economic Development and Trade) AGENDA (Please note that the following seminar agenda is a draft and subject to change) Date and Time: April 14th, 2008 (Monday) 9:00 – 13:30 Location: Westin Harbour Castle Hotel 1 Harbour Square · Toronto, Ontario 09:00 Registration 09:30--09:35 Introduction of the event and quests 09:35--09:40 Opening remarks by Mr. Zhang Weiguo, vice governor of Jiangsu 09:40--09:45 Welcome remarks by Mr. Dalton McGuinty, Ontario premier (TBC) 09:45--09:50 Introduction of Jiangsu biotech industry, by Mr. Fei Shaoyun, Deputy Director General of JSDFTEC 09:50--10:00 Introduction of Ontario biotech industry by MRI (TBC) 10:00--10:30 Self-introduction of Jiangsu pharmaceutical / biotech companies 10:30--11:00 Self-introduction of Ontario pharmaceutical / biotech companies 11:00--11:30 Networking time 11:30--13:30 Networking luncheon / one-on-one meetings Jingsu Pharmaceutical R&D Delegation Company 1 - Yangtze River Pharmaceutical Park......................................................................................................................2 Company 2 – Greenfield Pharmaceutical (Jiangsu) Co., Ltd......................................................................................................2 Company 3 – Synthetics China(SC)...........................................................................................................................................2 Company 4 - Yangtze River Pharmacy Group Co.,Ltd. ..............................................................................................................3 Company 5 - Administration Committee of Taizhou Medical Hi-tech Development Zone ...........................................................3 Company 6 - Jiangsu Carefree Medical Co.Ltd..........................................................................................................................3 Company 7- Nanjing Hicin Pharmaceutical Co., Ltd...................................................................................................................4 Company 8 - Polifarma (Nanjing) Co.l Ltd..................................................................................................................................4 Company 9 - Nanjing Dingye BTCR Inc.....................................................................................................................................5 Company 10 - Nanjing Chia-tai Tianqing Pharmaceutical Co., Ltd.............................................................................................5 Company 11 - Jiangsu Honghui Medical Co., Ltd.......................................................................................................................6 Company 12 - Jiangsu Nhwa Pharmaceutical Corporation Limited ...........................................................................................6 Company 13 – Jiangsu Baihua Industrial Group Co., Ltd...........................................................................................................7 Company 14 - Jiangsu Hansoh Pharmaceutical Co.,Ltd. ...........................................................................................................7 Company 15 - Jiangsu Kanion Pharmaceutical Co., Ltd ............................................................................................................8 Company 16 - Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.............................................................................................8 Company 17- Acesys Pharmatech .............................................................................................................................................9 Company 18 - Nanjing New & High Technology Economic Development Corporation ..............................................................9 Company 19 - The Administrative Committee of Pukou Economic Development Zone, Nanjing, Jiangsu...............................10 Company 20 - EnzMed (Nanjing) Co., Ltd................................................................................................................................10 Company 21 - Simcere Pharmaceutical Group ........................................................................................................................10 1 Company 1 - Yangtze River Pharmaceutical Park Address Gaogang district, Taizhou , Jiangsu Province Employees 2000 Brief Introduction As part of the Jiangsu Provincial pharmaceutical industry development plan, Centered on Yangzi River pharmaceutical Group, Yangtze River Pharmaceutical Park enlarges the scale and advantage of Taizhou medical industry, and extends the industrial chain. Yangtze River Pharmaceutial Group is leading medical enterprises of China. In 2007, both of its output value and sales have exceeded 12 billion yuan, ranking first in Chinese medical industry in sales revenue and profit payments and tax turnover, being among the largest Chinese medical enterprises. Main products Chemistry medicine and Chinese traditional medicine, Medicine & health care products, Medical equipment and appliance, Medical materials, Pharmaceutical equipment and medical packing Cooperation plan Medicine & health care products, Medical equipment and appliance, Medical materials, Pharmaceutical equipment and medical packing Approaches to cooperation Sole ownership, Cooperative business operation Company 2 – Greenfield Pharmaceutical (Jiangsu) Co., Ltd. Address 38 Taijiu Road, Hailing District, Taizhou, Jiangsu Province P.R.China www.gfpharm.com Employees 150 Brief Introduction Greenfield pharmaceutical (jiangsu) company was a joint venture set up in august 2002.The origin of which was taizhou biochemical pharmaceutical company (set up in 1970).The company is dedicated in development, manufacture and selling of tablets ,capsules, granules, small volume injection and pharmaceutical raw material coenzyme Q10, chondroitin sulfate, cytochromum C. Main products The company is dedicated in development, manufacture and selling of tablets, capsules, granules, small volume injection and pharmaceutical raw material coenzyme Q10,chondroitin sulfate, cytochromum C. Cooperation plan Visit pharmaceutical factory. Find out OEM. Company 3 – Synthetics China(SC) Address Qiyu County, Taixin City, Jiangsu www.synchina.com Employees 360 Brief Introduction Synthetics China(SC), an International Company established in 2002, is located in the northwest region of Shanghai and across the Yangtze River. SC is a Swiss-Chinese joint venture by Synthetics International AG and Jiangsu Zhongdan Group Co., Ltd. SC is becoming a key player in the “Fine Chemical” Industry, in addition to our product portfolio SC also provide custom service on a world wide basis, supplying intermediates, active ingredients and formulation to the Pharmaceutical and Agrochemical industries. SC has passed ISO9001, ISO14001, OHSAS 18001, GMP and GSP certifications. SC is a registered company with FDA and EDQM; Main products Pharmaceutical Intermediates and AP; Agrochemical Intermediates and AI; Formulation; Special fine chemicals； 2 Cooperation plan with well-known medicine and pesticide manufacturers; Intent to cooperate; production Cooperation; Cooperation: research and development, test and production Company 4 - Yangtze River Pharmacy Group Co.,Ltd. Address 1 Yangzijiang South Road TaiZhou, JiangSu Province www.yangtzeriver.com Employees 5000 Brief Introduction Founded in 1971, Yangtze River Pharmaceutical Group is a large pharmaceuticals group with a strong reputation nationwide. Its headquarters is located in Taizhou, an ancient city with a history of over a thousand years on the bank of Yangtze River within Yangtze Delta Economic Circle near Shanghai and Nanjing. There are 12 holding and shareholding companies in zhe group. At present,it covers an area of over 2 million square meters and employs a staff of over 5,000 people. Main products There are eleven kinds of pharmaceutical products produced in our company which include troche, capsules, granules, oral solutions, syrups, ointments, Freeze Dried products, as well as large and small volume Liquid injections. Meanwhile, we have produced dozens
Recommended publications
  • SGS-Safeguards 04910- Minimum Wages Increased in Jiangsu -EN-10

    SGS-Safeguards 04910- Minimum Wages Increased in Jiangsu -EN-10

    SAFEGUARDS SGS CONSUMER TESTING SERVICES CORPORATE SOCIAL RESPONSIILITY SOLUTIONS NO. 049/10 MARCH 2010 MINIMUM WAGES INCREASED IN JIANGSU Jiangsu becomes the first province to raise minimum wages in China in 2010, with an average increase of over 12% effective from 1 February 2010. Since 2008, many local governments have deferred the plan of adjusting minimum wages due to the financial crisis. As economic results are improving, the government of Jiangsu Province has decided to raise the minimum wages. On January 23, 2010, the Department of Human Resources and Social Security of Jiangsu Province declared that the minimum wages in Jiangsu Province would be increased from February 1, 2010 according to Interim Provisions on Minimum Wages of Enterprises in Jiangsu Province and Minimum Wages Standard issued by the central government. Adjustment of minimum wages in Jiangsu Province The minimum wages do not include: Adjusted minimum wages: • Overtime payment; • Monthly minimum wages: • Allowances given for the Areas under the first category (please refer to the table on next page): middle shift, night shift, and 960 yuan/month; work in particular environments Areas under the second category: 790 yuan/month; such as high or low Areas under the third category: 670 yuan/month temperature, underground • Hourly minimum wages: operations, toxicity and other Areas under the first category: 7.8 yuan/hour; potentially harmful Areas under the second category: 6.4 yuan/hour; environments; Areas under the third category: 5.4 yuan/hour. • The welfare prescribed in the laws and regulations. CORPORATE SOCIAL RESPONSIILITY SOLUTIONS NO. 049/10 MARCH 2010 P.2 Hourly minimum wages are calculated on the basis of the announced monthly minimum wages, taking into account: • The basic pension insurance premiums and the basic medical insurance premiums that shall be paid by the employers.
  • Mobile Monitoring of Urban Air Quality at High Spatial Resolution by Low

    Mobile Monitoring of Urban Air Quality at High Spatial Resolution by Low

    Mobile monitoring of urban air quality at high spatial resolution by low-cost sensors: Impacts of COVID-19 pandemic lockdown Shibao Wang1, Yun Ma1, Zhongrui Wang1, Lei Wang1, Xuguang Chi1, Aijun Ding1, Mingzhi Yao2, Yunpeng Li2, Qilin Li2, Mengxian Wu3, Ling Zhang3, Yongle Xiao3, Yanxu Zhang1 5 1School of Atmospheric Sciences, Nanjing University, Nanjing, China 2Beijing SPC Environment Protection Tech Company Ltd., Beijing, China 3Hebei Saihero Environmental Protection Hi-tech. Company Ltd., Shijiazhuang, China Correspondence: Yanxu Zhang ([email protected]) Abstract. The development of low-cost sensors and novel calibration algorithms provides new hints to complement 10 conventional ground-based observation sites to evaluate the spatial and temporal distribution of pollutants on hyperlocal scales (tens of meters). Here we use sensors deployed on a taxi fleet to explore the air quality in the road network of Nanjing over the course of a year (Oct. 2019–Sep. 2020). Based on GIS technology, we develop a grid analysis method to obtain 50 m resolution maps of major air pollutants (CO, NO2, and O3). Through hotspots identification analysis, we find three main sources of air pollutants including traffic, industrial emissions, and cooking fumes. We find that CO and NO2 concentrations show a pattern: 15 highways > arterial roads > secondary roads > branch roads > residential streets, reflecting traffic volume. While the O3 concentrations in these five road types are in opposite order due to the titration effect of NOx. Combined the mobile measurements and the stationary stations data, we diagnose that the contribution of traffic-related emissions to CO and NO2 are 42.6 % and 26.3 %, respectively.
  • Pharma China0409-285.P65

    Pharma China0409-285.P65

    TM C O N T E N T S ○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○ ○○○ I s s u e Editorial Mentholatum sues XiAn Meichen over Market Dynamics Brew New Order for trademark infringements 14 Chinese Pharma 2 API/Bulk Drugs 32 News in Focus Huaxing expands capacity of Amoxicillin MOH releases results of the 4th and 6-APA 14 APRIL National Health Service Survey 4 NCPG/DSM likely to build major The Market antibiotic API facility in Changchun 14 2 0 0 9 Data Snaptshot: Chinese OTC Shandong Antibiotics granted Germany healthcare market 5 GMP certification 15 Nicholas Hall reports slower growth Hisun sees profits up sharply in 2008 15 of OTC GI market in China 5 Changzhou Yabang-QH builds new In This Issue Industry News cGMP API plant with help from J&J 15 Chinese pharma industry perfor- Shijiazhuang Pharma receives EDQM MNCs report another year of mance in 2008 and outlook in 2009 5 certification for Vitamin B12 15 sharp revenue growth in China MNCs report another year of sharp India likely to investigate China’s 6-APA 15 Many MNCs experienced growth 20% revenue growth in China 6 MOC issues list of authorized exporters or more in China last year amid global MNCs positions for the huge diabetes of ephedrine drugs 15 slowdown P6 market potential in China 6 Data Snapshot - COS certifications and Harbin Pharma reconsiders Chinese producers likely to emerge DMFs held by Chinese companies 16 overseas IPO as global players of recombinant Chinese API in 2008 – Output and Export In preparation, Harbin Pharmaceutical human insulin 6 Volumes Down 16 Group is working on major and minor M&A is likely to intensify for retail Product and R&D News acquisitions this year P8 pharmacy sector in 2009 7 AOB to initiate clinical trials of TCM drug Pfizer opens new sterile facility Guangzhou introduces online for UI in the U.S.
  • Table of Codes for Each Court of Each Level

    Table of Codes for Each Court of Each Level

    Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115
  • Annual Report 2013 Contents

    Annual Report 2013 Contents

    AMITY A member of Annual Report 2013 Contents 01 A Message from the General Secretary 03 Project Reports 03 Church and Social Services 07 Community Development, Disaster Management, Environmental Protection, HIV/AIDS Prevention and Public Health 11 Education and Orphan Fostering 15 Education and International Exchange 20 Social Welfare 24 NGO Development 28 Urban Community Services 31 Resource Development 34 Amity Foundation, Hong Kong 43 Amity Printing Co., Ltd. 45 Who We Are 45 Organizational Chart 46 Amity Staff 47 Statistics 47 Where the funds come from 47 Where the funds go 48 List of Institutional Partners 55 Auditors Reports 2013 AMITY 01 A Message from the General Secretary In mid-January 2014, the Center for Civil Society Studies of Peking University announced Top Ten Events in Social Sectors in China 2013, among which were direct registration of four types of NGOs as a result of reforming the dual management system, population policy shift from quantity control to structure optimization remarked by the adoption of two-child fertility policy for couples where either the husband or the wife is from a single child family, citizens’ actions urging the government to share the responsibility to address the haze-highlighted environmental problems, Rule of Law in China as a resolution of the 3rd Plenary Session of 18th CPC Central Committee accompanied by a nationwide debate on political and legal basis for China Dream, and smoother cooperation between NGOs and the government occurring during Ya'an earthquake where the emergency response mechanism for disaster relief was challenged. Reading through the Top Ten Events, we find that more and more public voices were heard and taken seriously and eventually became driving forces to social development.
  • China Pharmaceutical Newsletter

    China Pharmaceutical Newsletter

    Volume VII 2011 CHINA PHARMACEUTICAL ڵNEWSLETTER З֡Ԛ哦֡ଢ଼рࡗЗ แྼჯ)ཀৄDž዆ᄱᆶ၌ࠅິ SFDA Commissioner Shao Mingli SFDA Deputy Commissioner Wu Zhen of NPC Standing Committee attended the met with new Cuban Ambassador to meets the Head of Iran's Innovation and meeting. Chen Zhu, the Health Minister China On September 29, 2011, Shao Technology Cooperation Center On the & Chairman of the Forum attended the Mingli, Commissioner of SFDA met morning of September 6, 2011, Wu Zhen, forum and delivered a speech. with Mr. ALberto Jesus Blanco Silva, the SFDA Deputy Commissioner, met with the Chen Zhu said in his speech, through new Cuban Ambassador Extraordinary visiting Mr. Hamidreza Amirinia, Head of 30 years of reform and opening up, and Plenipotentiary to China, and his Innovation and Technology Cooperation China's GDP has maintained a 10% entourage in Beijing. The two sides Center of Iran. Both parties exchanged growth in 30 consecutive years, and held in-depth discussions on further views on enhancing mutual exchanges and created an economic miracle. In 2010, strengthening the bilateral cooperation in understanding, and promoting cooperation China's GDP had ranked second in the WKH¿HOGVRIELRORJLFDl products and drug LQWKH¿HOGRIWUDGLWLRQDO&KLQHVHPHGLFLQH world. In the 21st century, the Chinese safety supervision. (September 30, 2011) and biopharmaceuticals. (September 8, 2011) Government pays more attention to social SFDA Deputy Commissioner Wu development, taking the alleviation of SFDA Deputy Commissioner Bian Zhen meets the delegation of MHLW On poverty and improvement of health care, Zhenjia attends the APEC LSIF Drug the morning of August 23, 2011, Wu Zhen, education, housing, and employment, etc.
  • Transmissibility of Hand, Foot, and Mouth Disease in 97 Counties of Jiangsu Province, China, 2015- 2020

    Transmissibility of Hand, Foot, and Mouth Disease in 97 Counties of Jiangsu Province, China, 2015- 2020

    Transmissibility of Hand, Foot, and Mouth Disease in 97 Counties of Jiangsu Province, China, 2015- 2020 Wei Zhang Xiamen University Jia Rui Xiamen University Xiaoqing Cheng Jiangsu Provincial Center for Disease Control and Prevention Bin Deng Xiamen University Hesong Zhang Xiamen University Lijing Huang Xiamen University Lexin Zhang Xiamen University Simiao Zuo Xiamen University Junru Li Xiamen University XingCheng Huang Xiamen University Yanhua Su Xiamen University Benhua Zhao Xiamen University Yan Niu Chinese Center for Disease Control and Prevention, Beijing City, People’s Republic of China Hongwei Li Xiamen University Jian-li Hu Jiangsu Provincial Center for Disease Control and Prevention Tianmu Chen ( [email protected] ) Page 1/30 Xiamen University Research Article Keywords: Hand foot mouth disease, Jiangsu Province, model, transmissibility, effective reproduction number Posted Date: July 30th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-752604/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/30 Abstract Background: Hand, foot, and mouth disease (HFMD) has been a serious disease burden in the Asia Pacic region represented by China, and the transmission characteristics of HFMD in regions haven’t been clear. This study calculated the transmissibility of HFMD at county levels in Jiangsu Province, China, analyzed the differences of transmissibility and explored the reasons. Methods: We built susceptible-exposed-infectious-asymptomatic-removed (SEIAR) model for seasonal characteristics of HFMD, estimated effective reproduction number (Reff) by tting the incidence of HFMD in 97 counties of Jiangsu Province from 2015 to 2020, compared incidence rate and transmissibility in different counties by non -parametric test, rapid cluster analysis and rank-sum ratio.
  • Risk Assessment of Urban Rainstorm Disaster Based on Multi-Layer Weighted Principal Component Analysis: a Case Study of Nanjing, China

    Risk Assessment of Urban Rainstorm Disaster Based on Multi-Layer Weighted Principal Component Analysis: a Case Study of Nanjing, China

    International Journal of Environmental Research and Public Health Article Risk Assessment of Urban Rainstorm Disaster Based on Multi-Layer Weighted Principal Component Analysis: A Case Study of Nanjing, China Junfei Chen 1,2,3,* , Juan Ji 1, Huimin Wang 1,4, Menghua Deng 1 and Cong Yu 1 1 Business School, Hohai University, Nanjing 211100, China; [email protected] (J.J.); [email protected] (H.W.); [email protected] (M.D.); [email protected] (C.Y.) 2 Yangtze Institute for Conservation and Development, Hohai University, Nanjing 210098, China 3 Research Institute of Jiangsu Yangtze River Conservation and High-Quality Development, Nanjing 210098, China 4 State Key Laboratory of Hydrology-Water Resources and Hydraulic Engineering, Hohai University, Nanjing 210098, China * Correspondence: [email protected]; Tel.: +86-25-6851-4613 Received: 26 June 2020; Accepted: 29 July 2020; Published: 30 July 2020 Abstract: Nanjing city is taken as a case in this urban rainstorm disaster risk research. Using the data of meteorology and social-economy statistics of Nanjing area, the paper selected ten indicators to establish the risk assessment system of urban rainstorm disaster from the aspects of the vulnerability of hazard-affected body, the fragility of disaster-pregnant environment, and the danger of hazard factors. Multi-layer weighted principal component analysis (MLWPCA) is an extension of the principal component analysis (PCA). The MLWPCA is based on factor analysis for the division subsystem. Then the PCA is used to analyze the indicators in each subsystem and weighted to synthesize. ArcGIS is used to describe regional differences in the urban rainstorm disaster risk.
  • Huai River Basin Flood Management and Drainage Improvement Project Environmental Assessment

    Huai River Basin Flood Management and Drainage Improvement Project Environmental Assessment

    PEOPLE’S REPUBLIC OF CHINA Public Disclosure Authorized Huai River Basin Flood Management and Drainage Improvement Project Environmental Assessment Executive Summary Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Yellow River Water Resources Protection Institute February 2009 CONTENTS 1 INTRODUCTION ....................................................................................................................................... 1 1.1 CONTEXT ................................................................................................................................................. 1 1.2 LAWS, REGULATIONS AND POLICIES ON WHICH THE PROJECT IS BASED .................................................. 2 1.3 DEVELOPMENT OF EA REPORTS .............................................................................................................. 2 2 PROJECT DESCRIPTION ........................................................................................................................ 4 2.1 PROJECT OBJECTIVES .............................................................................................................................. 4 2.2 PROJECT SCOPE ....................................................................................................................................... 4 2.3 LAND OCCUPATION AND RESETTLEMENT PLANS OF THE PROJECT ........................................................... 6 3 ENVIRONMENTAL BASELINE SITUATION ......................................................................................
  • Eco City Development in China: Addressing the Policy Implementation Challenge

    Eco City Development in China: Addressing the Policy Implementation Challenge

    This is an Open Access document downloaded from ORCA, Cardiff University's institutional repository: http://orca.cf.ac.uk/89105/ This is the author’s version of a work that was submitted to / accepted for publication. Citation for final published version: de Jong, Martin, Yu, Chang, Joss, Simon, Wennersten, Ronald, Yu, Li, Zhang, Xiaoling and Ma, Xin 2016. Eco city development in China: addressing the policy implementation challenge. Journal of Cleaner Production 134 (A) , pp. 31-41. 10.1016/j.jclepro.2016.03.083 file Publishers page: http://dx.doi.org/10.1016/j.jclepro.2016.03.083 <http://dx.doi.org/10.1016/j.jclepro.2016.03.083> Please note: Changes made as a result of publishing processes such as copy-editing, formatting and page numbers may not be reflected in this version. For the definitive version of this publication, please refer to the published source. You are advised to consult the publisher’s version if you wish to cite this paper. This version is being made available in accordance with publisher policies. See http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications made available in ORCA are retained by the copyright holders. Accepted Manuscript Eco city development in China: addressing the policy implementation challenge Martin de Jong, Chang Yu, Simon Joss, Ronald Wennersten, Li Yu, Xiaoling Zhang, Xin Ma PII: S0959-6526(16)30152-4 DOI: 10.1016/j.jclepro.2016.03.083 Reference: JCLP 6932 To appear in: Journal of Cleaner Production Received Date: 1 October 2015 Revised Date: 5 March 2016 Accepted Date: 9 March 2016 Please cite this article as: de Jong M, Yu C, Joss S, Wennersten R, Yu L, Zhang X, Ma X, Eco city development in China: addressing the policy implementation challenge, Journal of Cleaner Production (2016), doi: 10.1016/j.jclepro.2016.03.083.
  • Ganglong China Property Group Limited 港龍中國地產集團有限公司

    Ganglong China Property Group Limited 港龍中國地產集團有限公司

    The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Ganglong China Property Group Limited 港龍中國地產集團有限公司 (Incorporated in the Cayman Islands with limited liability) (the “Company”) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sponsor, advisers or member of the underwriting syndicate that: 1. this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; 2. the publication of this document or supplemental, revised or replacement pages on the Exchange’s website does not give rise to any obligation of the Company, its sponsor, advisers or members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction. There is no assurance that the Company will proceed with the offering; 3.
  • Unaudited Operating Statistics for September 2020

    Unaudited Operating Statistics for September 2020

    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. (incorporated in Hong Kong with limited liability) (Stock Code: 81) UNAUDITED OPERATING STATISTICS FOR SEPTEMBER 2020 The board of directors (the “Board”) of China Overseas Grand Oceans Group Limited (the “Company”) is pleased to announce certain unaudited operating statistics of the Company and its subsidiaries (the “Group”) and its associates and joint ventures (collectively, the “China Overseas Grand Oceans Series of Companies”) as follows: For September 2020, the property contracted sales of the China Overseas Grand Oceans Series of Companies amounted to RMB8,062,000,000 and the contracted GFA reached 610,600 square meters, with year-on-year increase of 101.6% and 62.4% respectively. From January to September 2020, the total property contracted sales amounted to RMB44,604,000,000 and the total contracted GFA reached 3,729,000 square meters, with year-on-year increase of 15.6% and 4.6% respectively. As at the end of September 2020, the property subscription sales amounted to RMB1,604,000,000 and the subscription GFA reached 109,300 square meters. In September 2020, the Group acquired four new projects in Tianshui, Gansu Province, Tangshan, Hebei Province, Lanzhou, Gansu Province and Shantou, Guangdong Province with an attributable GFA of 1,358,444.80 square meters and the total attributable land cost was RMB6,505,300,000.